Clinical issues in the diagnosis and treatment of tuberculosis patients with positive antibody to hepatitis C virus
10.3969/j.issn.1001-5256.2018.12.036
- VernacularTitle:结核病合并抗-HCV阳性患者临床诊疗的常见问题
- Author:
Shuhua ZHAN
1
;
Qing CHEN
;
Shiwu MA
Author Information
1. Kunming General Hospital of Chengdu Military Command, Kunming Medical University, Kunming 650000, China
- Publication Type:Research Article
- Keywords:
tuberculosis;
hepacivirus;
drug-drug interactions;
drug-induced liver injury;
virus activation;
review
- From:
Journal of Clinical Hepatology
2018;34(12):2672-2676
- CountryChina
- Language:Chinese
-
Abstract:
Tuberculosis patients with positive antibody to hepatitis C virus (TB-HCV patients) are often seen in clinical practice, and these TB-HCV patients include those with HCV infection. That makes the clinical management and diagnosis/treatment of TB-HCV difficult. This article introduces the prevalence of TB-HCV around the world, and analyzes the potential issues in the diagnosis and treatment of TB-HCV patients, such as drug-drug interactions, drug-induced liver injury, HCV reactivation, and TB reactivation. Through this review, it is recommended that the management should be strengthened and the appropriate therapeutic regimen should be selected in the diagnosis and treatment of TB-HCV patients.
